反氧反应的聚合物纳米囊用于增强瘤向的抗菌的递送
Lin Tang1,2,3, Yajian Li4,5, Xiaoyin Lv1
1Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|February 19, 2026
概括
这项研究引入了一种新的纳米囊平台,用于输送抗癌抗微生物 (AMP). 该系统增强瘤向性,降低毒性,提高癌症治疗的有效性.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 抗微生物 (AMP) 显示出作为抗癌药物的潜力.
- 目前的限制包括蛋白质溶解不稳定性,全身毒性和血液溶解.
研究的目的:
- 开发一种可氧化还原反应的聚合物纳米囊平台,用于增强瘤向AMP的输送.
- 在癌症治疗中克服自由AMP的局限性.
主要方法:
- 使用二硫化物交叉连接的纳米囊 (nMEL) 以梅利丁 (MEL) 为模型.
- 包含用于活性向的甲酸配体 (nMEL-PBA).
- 评估稳定性,瘤积累,瘤生长抑制,肺丰富和生存率.
主要成果:
- 在生理条件下,nMEL表现为稳定,在瘤微环境中由谷氨触发的释放.
- 与自由MEL相比,nMEL的瘤积累率高出约4倍,瘤生长抑制率高出约80%.
- 在肺转移模型中,nMEL-PBA证明了增强的肺丰富和延长中位生存时间到43天.
结论:
- 纳米囊平台提供了系统稳定性,瘤选择性和微环境响应激活.
- 这一策略提供了一种可通用的方法来增强基于AMP的癌症治疗.
- 开发的系统克服了利用AMP治疗癌症的关键障碍.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
31
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
31
Modified-Release Drug Delivery Systems: Stimuli-Activated
26
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
26
Modified-Release Drug Delivery Systems: Site-Targeted
29
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
29


